Shares of Goldman Sachs Group Inc. GS inched 0.15% higher to $586.33 Monday, on what proved to be an all-around mixed trading ...

Goldman Sachs downgraded hospital stocks Universal Health Services (NYSE:UHS) and Tenet Healthcare (NYSE:THC) from buy to ...

Goldman Sachs (GS) closed the most recent trading day at $586.33, moving +0.15% from the previous trading session.

The Federal Reserve is likely to signal a slower future pace of easing when it meets later this week and then skip cutting ...

Artificial adoption by companies remains modest, with only 6.1% of U.S. firms currently utilizing AI to produce goods or ...

Goldman Sachs analyst Eric Sheridan initiated coverage on Grindr Inc (NYSE:GRND) with a Buy rating and a price target of $20.

Goldman Sachs Asset Management has agreed a more than €2bn deal to acquire drugmaker Synthon from BC Partners, according to people familiar with the matter, as it hopes to capitalise on demand for off ...

Unlike some recent RMBS deals, both exclude riskier interest-only loans and those supporting investment properties.

BC Partners has agreed to sell its majority stake in Synthon to Goldman Sachs Alternatives. Synthon is an international pharmaceutical company, with a platform specialized in developing, manufacturing ...

Consumer sentiment and spending will remain strong in 2025, with outsize gains for discretionary stocks, with some ...

Goldman Sachs expects "strategic" deals by companies to accelerate in 2025 including large-scale mergers and acquisitions, ...

Goldman Sachs received regulatory approval to sell funds in China, the latest U.S. investment bank to get a financial licence ...